logo
Select company
Select metric
-1849.39%EBIT Margin
VS
Market
4
Sector
16
Industry
29
History
53
$ 0.86Close
$ 0.79 - $ 3.1 52-Week Range
Ticker Information

Ticker

LEXX

Company Name

LEXARIA BIOSCIENCE CORP

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

LEXARIA BIOSCIENCE CORP - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

LEXX - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ -11.39M-1849.39%$ 615.92K
3/31/2025$ -9.38M-1784.18%$ 525.92K
12/31/2024$ -7.32M-1473.01%$ 496.92K
9/30/2024$ -5.8M-1248.25%$ 464.28K
6/30/2024$ -4.83M-1280.99%$ 376.85K
3/31/2024$ -5.44M-1409.68%$ 386K
12/31/2023$ -6.11M-2215.46%$ 276.01K
9/30/2023$ -6.71M-2967.41%$ 226.21K
6/30/2023$ -7M-2054.41%$ 340.79K
3/31/2023$ -7.02M-2022.11%$ 347.36K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • LEXARIA BIOSCIENCE CORP's latest trailing twelve months (TTM) EBIT % stands at -1062.2%.
  • Over the past 5 years, LEXARIA BIOSCIENCE CORP's average EBIT % has been -1716.52%.
  • The median EBIT % for LEXARIA BIOSCIENCE CORP during this period was -1628.59%
  • LEXARIA BIOSCIENCE CORP reached its highest EBIT % over the past 5 years at -354.31%.
  • The lowest EBIT % recorded by LEXARIA BIOSCIENCE CORP in the same timeframe -4105.74%

LEXARIA BIOSCIENCE CORP's EBIT % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT % Benchmarks
CompanyEBIT %
BRTX : BIORESTORATIVE THERAPIES INC -1771.91%IBIO : IBIO INC -4541.25%ERNA : ERNEXA THERAPEUTICS INC -7890.57%ICU : SEASTAR MEDICAL HOLDING CORP -1909.79%RLYB : RALLYBIO CORP -5473.32%LYRA : LYRA THERAPEUTICS INC -5041.17%PULM : PULMATRIX INC -2149.05%VYNE : VYNE THERAPEUTICS INC -8096.85%APRE : APREA THERAPEUTICS INC -1766.47%MGRX : MANGOCEUTICALS INC -2791.27%

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for LEXARIA BIOSCIENCE CORP is calculated as follows: EBIT [ $ -4.08M ] / Revenues [ $ 384.54K ]
(=) EBIT % [ -1062.2% ]

LEXX - EBIT Margin, Last 5 years

-4105.74%

Minimum

Jun 30, 2022

-354.31%

Maximum

Mar 31, 2021

-1716.52%

Average

-1628.59%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.55% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.55%
median9.01%
std23.96%